# Effects of MetAP2 Inhibition on Bioenergetics and Aging-associated Characteristics in Adipose Tissue in Healthy Participants

> **NCT05989035** · NA · COMPLETED · sponsor: **AdventHealth Translational Research Institute** · enrollment: 31 (actual)

## Conditions studied

- Aging

## Interventions

- **PROCEDURE:** Abdominal subcutaneous adipose tissue biopsy

## Key facts

- **NCT ID:** NCT05989035
- **Lead sponsor:** AdventHealth Translational Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-31
- **Primary completion:** 2021-03-25
- **Final completion:** 2024-02-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05989035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05989035, "Effects of MetAP2 Inhibition on Bioenergetics and Aging-associated Characteristics in Adipose Tissue in Healthy Participants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05989035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*